SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting
An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for ...
Read moreAn additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for ...
Read moreQ3W schedule of CRB-701 (SYS6002) demonstrates a 43% ORR and 71% DCR at predicted therapeutically relevant dosesAll assessable nectin-4 positive ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.